Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Alzheimer's pathology in primary progressive aphasia
Alzheimer's Disease Drug Candidates Stabilize A-beta Protein Native Structure by Interacting with the Hydrophobic Core
Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation
Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric A beta species in amyloid precursor protein transgenic mice
Alzheimer%26apos;s Disease, Oestrogen and Mitochondria: an Ambiguous Relationship
Alzheimer culprits: Cellular crossroads and interplay
Alzheimer's Disease Clinical Trials: Changing the Paradigm
Alzheimer's disease-associated polymorphisms in human OGG1 alter catalytic activity and sensitize cells to DNA damage
Alzheimer's disease genetic mutation evokes ultrastructural alterations: Correlation to an intracellular A beta deposition and the level of GSK-3 beta-P(Y216) phosphorylated form
Alzheimer's disease: a molecular mechanism, new hypotheses, and therapeutic strategies
Alzheimer disease: are we intervening too late?
Alzheimer's Disease and Neuronal Network Activity
Alzheimer's disease: Cholesterol a menace?
Alzheimer's Disease Affects Progenitor Cells through Aberrant beta-Catenin Signaling
Alzheimer's Disease and Oxidative Stress: A Review
Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1 beta levels and expression in peripheral blood mononuclear cells
Alzheimer's disease: current and future therapy
Alzheimer disease biomarkers and insights into mild cognitive impairment
Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization
Alzheimer's disease: strategies for disease modification
Alzheimer's disease: progress in prediction
Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites
Alzheimer%26apos;s disease risk factor complement receptor 1 is associated with depression
Alzheimer's Disease: Pathological Mechanisms and Recent Insights
Alzheimer's disease and related disorders: specificity of young onset patients, including ethical aspects
Alzheimer's disease is associated with low density of the long CR1 isoform
Alzheimer's disease beyond APOE
Alzheimer's disease & metals: therapeutic opportunities
Alzheimer's Disease Neuroimaging Initiative in Europe
Alzheimer disease Can the exam predict the pathology?
Alzheimer's Disease: Another Target for Heparin Therapy
Alzheimer%26apos;s disease and type 2 diabetes: Two diseases, one common link?
Alzheimer's factors in postischemic dementia
Alzheimer Disease in a Mouse Model: MR Imaging-guided Focused Ultrasound Targeted to the Hippocampus Opens the Blood-Brain Barrier and Improves Pathologic Abnormalities and Behavior
Alzheimer's disease risk, obesity and tau: is insulin resistance guilty?
Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria
Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
Alzheimer's-Type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis
Alzheimer's disease, amyloid peptide and synaptic dysfunction
Alzheimer's Disease Brain-Derived Amyloid-beta-Mediated Inhibition of LTP In Vivo Is Prevented by Immunotargeting Cellular Prion Protein
Alzheimer Presenilin-1 Mutations Dramatically Reduce Trimming of Long Amyloid beta-Peptides (A beta) by gamma-Secretase to Increase 42-to-40-Residue A beta
Alzheimer disease: Autosomal dominant forms
Alzheimer's disease, metal ions and metal homeostatic therapy
Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family
Alzheimer's disease, aneuploidy and neurogenesis
Alzheimer's disease and methylenetetrahydrofolate reductase gene polymorphisms: a potential nutrigenomic approach for Mexico.
Alzheimer CSF biomarkers in routine clinical setting
Alzheimer's disease and natural cognitive aging may represent adaptive metabolism reduction programs
Alzheimer's Disease And Type 2 Diabetes: Exploring The Association To Obesity And Tyrosine Hydroxylase
Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy
Alzheimer's-Related Peptide Amyloid-beta Plays a Conserved Role in Angiogenesis
Alzheimer's disease: on the verges of treatment and prevention
Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention
Alzheimer's A42 and A40 peptides form interlaced amyloid fibrils
Alzheimer's Disease: Recent Advances and Future Perspectives
Alzheimer disease controls cancer - Concerning the apoptogenic interaction of cell membrane-standing type-1 VDAC and amyloid peptides via GxxxG motifs
Alzheimer's disease and chronic periodontitis: Is there an association?
Alzheimer's Disease: Genetic Polymorphisms and Rate of Decline
Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies
Alzheimer's CSF markers in older schizophrenia patients
Alzheimer's disease and glaucoma Response
Alzheimer A beta disrupts the mitotic spindle and directly inhibits mitotic microtubule motors
Alzheimer disease: An interactome of many diseases
Alzheimer's disease drug-development pipeline: few candidates, frequent failures
Alzheimer's disease and the amyloid cascade hypothesis: Ten years on
Alzheimer%26apos;s Disease: Pathophysiology and Applications of Magnetic Nanoparticles as MRI Theranostic Agents
Alzheimer's Disease, Astrocytes and Kynurenines
Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain
Alzheimer's Disease: Brain Desmosterol Levels
Alzheimer's disease: new approaches to drug discovery
Alzheimer's disease and post-operative cognitive dysfunction
Alzheimer's disease, genes, and environment: The value of international studies
Alzheimer's disease: the new promise
Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein
Alzheimer's disease in the zebrafish: where can we take it?
Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches
Alzheimer%26apos;s disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic-and community-based samples
Alzheimer's disease and diet: a systematic review
Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatments
Alzheimer's Disease is an Important Risk Factor of Fractures: a Meta-analysis of Cohort Studies
Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State
Alzheimer's disease and Toxoplasma gondii infection; seromolecular assess the possible link among patients
Alzheimer's Disease Detection by Pseudo Zernike Moment and Linear Regression Classification